ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,000 | -100.0% | 16 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $7,549,000 | +24.1% | 155,600 | 0.0% | 0.04% | +25.7% |
| Q1 2018 | $6,083,000 | -55.2% | 155,600 | -51.4% | 0.04% | -52.7% |
| Q4 2017 | $13,580,000 | +11.6% | 320,000 | -1.8% | 0.07% | +5.7% |
| Q3 2017 | $12,166,000 | +21.9% | 326,000 | -0.8% | 0.07% | +20.7% |
| Q2 2017 | $9,983,000 | +88.6% | 328,500 | +64.2% | 0.06% | +87.1% |
| Q1 2017 | $5,294,000 | +314.9% | 200,000 | +300.0% | 0.03% | +287.5% |
| Q4 2016 | $1,276,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |